Sergio E Rodriguez
Overview
Explore the profile of Sergio E Rodriguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carpenter A, Price E, Stein S, Beron A, Divis A, Mix S, et al.
J Am Vet Med Assoc
. 2024 Nov;
263(2):149-152.
PMID: 39549410
Rabies is a fatal encephalitic disease affecting all mammals. This report describes identification of raccoon rabies virus variant isolated from a stray kitten in an urban Midwestern city that is...
2.
Stein S, Beron A, Nelson K, Price E, Rodriguez S, Shelus V, et al.
MMWR Morb Mortal Wkly Rep
. 2024 Oct;
73(41):933-935.
PMID: 39418219
On September 28, 2023, a kitten aged approximately 6 weeks found in Omaha, Nebraska, had test results positive for rabies at the Nebraska Veterinary Diagnostic Center (NVDC) after dying with...
3.
Scholte F, Rodriguez S, Welch S, Davies K, Genzer S, Coleman-McCray J, et al.
J Infect Dis
. 2023 Dec;
230(2):438-443.
PMID: 38064677
Nipah virus (NiV) is a highly pathogenic paramyxovirus. The Syrian hamster model recapitulates key features of human NiV disease and is a critical tool for evaluating antivirals and vaccines. Here...
4.
Welch S, Spengler J, Genzer S, Coleman-McCray J, Harmon J, Sorvillo T, et al.
Sci Adv
. 2023 Aug;
9(31):eadh4057.
PMID: 37540755
Nipah virus (NiV) causes a highly lethal disease in humans who present with acute respiratory or neurological signs. No vaccines against NiV have been approved to date. Here, we report...
5.
Yadav P, Patil D, Kumar S, Bergeron E, Rodriguez S
Front Med (Lausanne)
. 2023 Jul;
10:1215309.
PMID: 37448801
No abstract available.
6.
Mears M, Rodriguez S, Schmitz K, Padilla A, Biswas S, Cajimat M, et al.
Antiviral Res
. 2022 Sep;
207:105401.
PMID: 36049554
Crimean-Congo hemorrhagic fever (CCHF) is a medically relevant tick-borne viral disease caused by the Bunyavirus, Crimean-Congo hemorrhagic fever virus (CCHFV). CCHFV is endemic to Asia, the Middle East, South-eastern Europe,...
7.
Shepard J, Freitas B, Rodriguez S, Scholte F, Baker K, Hutchison M, et al.
Front Immunol
. 2022 Jan;
12:794664.
PMID: 35058932
Post-translational modification of host and viral proteins by ubiquitin and ubiquitin-like proteins plays a key role in a host's ability to mount an effective immune response. Avian species lack a...
8.
Rodriguez S, Hawman D, Sorvillo T, ONeal T, Bird B, Rodriguez L, et al.
Antiviral Res
. 2022 Jan;
199:105244.
PMID: 35026307
Human infection with Crimean-Congo hemorrhagic fever virus (CCHFV), a tick-borne pathogen in the family Nairoviridae, can result in a spectrum of outcomes, ranging from asymptomatic infection through mild clinical signs...
9.
Spengler J, Welch S, Scholte F, Rodriguez S, Harmon J, Coleman-McCray J, et al.
Antiviral Res
. 2021 May;
191:105090.
PMID: 34044061
Crimean-Congo hemorrhagic fever virus (CCHFV) causes mild to severe and fatal disease in humans. Person-to-person transmission is common, necessitating the availability of rapidly deliverable therapeutic and prophylactic interventions to mitigate...
10.
Sorvillo T, Rodriguez S, Hudson P, Carey M, Rodriguez L, Spiropoulou C, et al.
Trop Med Infect Dis
. 2020 Jul;
5(3).
PMID: 32645889
Crimean-Congo hemorrhagic fever virus (CCHFV) infection is identified in the 2018 World Health Organization Research and Development Blueprint and the National Institute of Allergy and Infectious Diseases (NIH/NIAID) priority A...